The Food and Drug Administration (FDA) and the Anti-Red Tape Authority (ARTA) have committed to empower the local pharmaceutical industry by ensuring that policies are updated and responsive to the needs of the industry.
“We at FDA are committed to supporting PCPI and the local pharmaceutical companies by ensuring that FDA policies are updated to meet the local pharmaceutical industry needs and that industry-related processes are accessible and efficient,” FDA Director-General Samuel A. Zacate said during the first general assembly of the Philippine Chamber of the Pharmaceutical Industry (PCPI), the major industry group of Filipino-owned pharmaceutical companies.
ARTA Director-General Ernesto Perez also vowed to work closely with the FDA and the Department of Health to streamline and expedite processes.
“Our aim is to leverage our collective strengths to pave the way for the rise of a Bagong Pilipinas. We are confident that through our unified efforts with FDA and PCPI, we can continue to empower the Philippine pharmaceutical industry to grow and contribute to the local economy,” said Perez.
PCPI’s newly-inducted president Dr. Lloyd Balajadia added: “We at the PCPI look forward to working together with FDA and ARTA to achieve our vision of a globally competitive and sustainable Philippine pharmaceutical industry that provides Filipinos with high-quality and affordable medicines.”